Study Preview
Study Title and Description
Randomized Comparative Study of the U- and H-Type Approaches of the TVT-Secur Procedure for the Treatment of Female Stress Urinary Incontinence: One-Year Follow-Up.
Key Questions Addressed
1 | Sling vs Comparator RCT outcomes (excluding AEs) | |
2 | Sling Adverse Events |
Primary Publication Information
Title | Randomized Comparative Study of the U- and H-Type Approaches of the TVT-Secur Procedure for the Treatment of Female Stress Urinary Incontinence: One-Year Follow-Up. |
Author | Kim JJ., Lee YS., Lee KS. |
Country | Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. |
Year | 2010 |
Numbers |
Pubmed ID: 20428427 1424 (internal) |
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Sling vs Comparator RCT outcomes (excluding AEs)
Arms
Number | Title | Description | Comments |
---|---|---|---|
1 | TVT-Secur U | ||
2 | TVT-Secur H |
Question... Follow Up | Answer | Follow-up Answer | |
---|---|---|---|
Country | South Korea | ||
Outcome Categories Reported | Objective SUI | ||
Quality of life | |||
OR outcomes/complications (not "AEs") | |||
Population (reason for surgery etc.) | Urodynamic SUI | ||
Intrinsic sphincter deficiency | |||
RCT Comparison Category | Minisling vs. Other | ||
Multicenter | No | ||
Institution Type | Academic hospital | ||
Number of surgeons performing procedures | 1 | ||
Surgeons' Training | Urology | ||
Residents or fellows performing surgery? | No | ||
Study Quality (overall) | B (fair) | ||
Study Sponsor/Funding ... | Other ... | Unclear |
Baseline Characteristics
Question | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Total | Comments | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Answer | Follow-up | Answer | Follow-up | Answer | Follow-up | Answer | Follow-up | Answer | Follow-up | ||
No. Randomized | 53 | 62 | |||||||||
Mean Age | 55.21 | 56.6 | |||||||||
Post-Op Follow-Up Interval (Maximum) | 12 mo | 12 mo |
Results & Comparisons
Results Data
Outcome: Satisfaction Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
12 months |
Percentage | 82.9 | 84.3 | 0.858 |
Outcome: Perceived surgery was benefit Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
12 months |
Percentage | 80.5 | 86.3 | 0.455 |
Outcome: Recommend to a friend Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
12 months |
Percentage | 87.8 | 88.0 | 0.442 |
Outcome: Would undergo same surgery again Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
12 months |
Percentage | 87.8 | 86.3 | 0.800 |
Outcome: "Cure" Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
12 months |
Percentage | 88.7 | 87.1 | 0.796 | |||
N Analyzed | 53 | 62 | |||||
Counts | 47 | 54 |
Outcome: Time in OR Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.114 | |||
Mean | 14.77 | 13.42 | |||||
Standard Deviation | 6.35 | 5.13 |
Outcome: EBL Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.645 | |||
Mean | 56.45 | 66.36 | |||||
Standard Deviation | 45.31 | 71.63 |
Outcome: Immediate Postop Pain VAS Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.926 | |||
Mean | 2.18 | 2.09 | |||||
Standard Deviation | 2.00 | 1.77 |
Outcome: I-QoL - Total Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 39.32 | 43.04 | |||||
Standard Deviation | 21.32 | 22.38 | |||||
12 months |
N Analyzed | 53 | 62 | 0.6070 | |||
Mean | 70.56 | 71.89 | |||||
Standard Deviation | 16.43 | 18.42 |
Outcome: I-QoL - Avoidance and limiting behavior Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 44.42 | 75.63 | |||||
Standard Deviation | 22.72 | 18.44 | |||||
12 months |
N Analyzed | 53 | 62 | 0.7551 | |||
Mean | 75.63 | 78.52 | |||||
Standard Deviation | 18.44 | 19.31 |
Outcome: I-QoL - Psychosocial impacts Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 46.34 | 50.04 | |||||
Standard Deviation | 26.08 | 27.44 | |||||
12 months |
N Analyzed | 53 | 62 | 0.4139 | |||
Mean | 77.88 | 78.01 | |||||
Standard Deviation | 17.12 | 20.66 |
Outcome: I-QoL - Social embarrassment Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 36.04 | 39.92 | |||||
Standard Deviation | 26.01 | 28.29 | |||||
12 months |
N Analyzed | 53 | 62 | 0.7216 | |||
Mean | 82.35 | 84.00 | |||||
Standard Deviation | 22.70 | 23.65 |
Outcome: BLUFTS - filling symptoms Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 4.87 | 5.08 | |||||
Standard Deviation | 2.63 | 2.72 | |||||
12 months |
N Analyzed | 53 | 62 | 0.4693 | |||
Mean | 2.80 | 2.97 | |||||
Standard Deviation | 1.95 | 2.37 |
Outcome: BLUFTS - voiding symptoms Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 1.75 | 1.81 | |||||
Standard Deviation | 2.66 | 2.28 | |||||
12 months |
N Analyzed | 53 | 62 | 0.1733 | |||
Mean | 1.84 | 1.36 | |||||
Standard Deviation | 2.64 | 1.94 |
Outcome: BLUFTS - incontinence symptoms Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 9.00 | 7.66 | |||||
Standard Deviation | 3.72 | 3.87 | |||||
12 months |
N Analyzed | 53 | 62 | 0.0210 | |||
Mean | 1.60 | 2.47 | |||||
Standard Deviation | 2.42 | 3.28 |
Outcome: BLUFTS - sexual function Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 1.30 | 1.08 | |||||
Standard Deviation | 1.54 | 1.41 | |||||
12 months |
N Analyzed | 53 | 62 | 0.3822 | |||
Mean | 0.20 | 0.42 | |||||
Standard Deviation | 0.45 | 1.12 |
Outcome: BLUFTS - QoL Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 7.87 | 6.89 | |||||
Standard Deviation | 4.55 | 4.22 | |||||
12 months |
N Analyzed | 53 | 62 | 0.2857 | |||
Mean | 1.98 | 2.15 | |||||
Standard Deviation | 3.31 | 3.32 |
Outcome: Max Flow (Qmax) Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 22.65 | 25.05 | |||||
Standard Deviation | 7.49 | 11.20 | |||||
12 months |
N Analyzed | 53 | 62 | 0.2048 | |||
Mean | 17.74 | 22.14 | |||||
Standard Deviation | 9.12 | 10.42 |
Outcome: PVR Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 15.19 | 19.80 | |||||
Standard Deviation | 19.89 | 29.99 | |||||
12 months |
N Analyzed | 53 | 62 | 0.3035 | |||
Mean | 24.00 | 40.29 | |||||
Standard Deviation | 23.35 | 46.04 |
Outcome: Diary - Nocturia Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 0.72 | 0.80 | |||||
Standard Deviation | 0.82 | 0.81 | |||||
12 months |
N Analyzed | 53 | 62 | 0.1740 | |||
Mean | 0.98 | 0.78 | |||||
Standard Deviation | 0.97 | 0.73 |
Outcome: Diary - Urgency episodes Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 2.54 | 2.79 | |||||
Standard Deviation | 3.25 | 3.74 | |||||
12 months |
N Analyzed | 53 | 62 | 0.3234 | |||
Mean | 2.42 | 1.55 | |||||
Standard Deviation | 3.24 | 2.23 |
Outcome: Diary - Urgency scale Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 2.07 | 211 | |||||
Standard Deviation | 1.00 | 0.98 | |||||
12 months |
N Analyzed | 53 | 62 | 0.8817 | |||
Mean | 1.85 | 1.89 | |||||
Standard Deviation | 1.18 | 0.96 |
Outcome: Incontinence VAS (I-VAS) Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 6.61 | 6.69 | |||||
Standard Deviation | 2.15 | 2.14 | |||||
12 months |
N Analyzed | 53 | 62 | 0.4354 | |||
Mean | 0.95 | 1.20 | |||||
Standard Deviation | 2.41 | 2.31 |
Outcome: Time til return to house work Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.624 | |||
Mean | 7.18 | 5.43 | |||||
Standard Deviation | 12.15 | 9.89 |
Outcome: Time til return to job Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.207 | |||
Mean | 9.33 | 6.64 | |||||
Standard Deviation | 9.69 | 8.27 |
Outcome: Time til return to social activity Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.347 | |||
Mean | 14.33 | 11.41 | |||||
Standard Deviation | 20.31 | 17.17 |
Outcome: Time til return to hobby Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.442 | |||
Mean | 14.84 | 11.08 | |||||
Standard Deviation | 15.11 | 12.67 |
Outcome: Time til return to sexual activity Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.885 | |||
Mean | 38.96 | 39.56 | |||||
Standard Deviation | 15.31 | 14.20 |
Extraction Form: Sling Adverse Events
Arms
Number | Title | Description | Comments |
---|---|---|---|
1 | Minisling retropubic | TVT-Secure U | |
2 | Minisling obturator | TVT-Secure H |
Question... Follow Up | Answer | Follow-up Answer | |
---|---|---|---|
Study Type | RCT | ||
Sling Category | Minisling H (obturator) | ||
Minsling U (retropubic) | |||
Adverse Event Ascertainment | Unclear/Not reported | ||
Was the Clavien-Dindo Classification of Surgical Complications system used? | No / Not reported | ||
Was a data safety monitoring board used? | No / Not reported | ||
Study Sponsor/Funding | Not reported |
Results & Comparisons
Results Data
Outcome: Satisfaction Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
12 months |
Percentage | 82.9 | 84.3 | 0.858 |
Outcome: Perceived surgery was benefit Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
12 months |
Percentage | 80.5 | 86.3 | 0.455 |
Outcome: Recommend to a friend Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
12 months |
Percentage | 87.8 | 88.0 | 0.442 |
Outcome: Would undergo same surgery again Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
12 months |
Percentage | 87.8 | 86.3 | 0.800 |
Outcome: "Cure" Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
12 months |
Percentage | 88.7 | 87.1 | 0.796 | |||
N Analyzed | 53 | 62 | |||||
Counts | 47 | 54 |
Outcome: Time in OR Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.114 | |||
Mean | 14.77 | 13.42 | |||||
Standard Deviation | 6.35 | 5.13 |
Outcome: EBL Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.645 | |||
Mean | 56.45 | 66.36 | |||||
Standard Deviation | 45.31 | 71.63 |
Outcome: Immediate Postop Pain VAS Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.926 | |||
Mean | 2.18 | 2.09 | |||||
Standard Deviation | 2.00 | 1.77 |
Outcome: I-QoL - Total Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 39.32 | 43.04 | |||||
Standard Deviation | 21.32 | 22.38 | |||||
12 months |
N Analyzed | 53 | 62 | 0.6070 | |||
Mean | 70.56 | 71.89 | |||||
Standard Deviation | 16.43 | 18.42 |
Outcome: I-QoL - Avoidance and limiting behavior Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 44.42 | 75.63 | |||||
Standard Deviation | 22.72 | 18.44 | |||||
12 months |
N Analyzed | 53 | 62 | 0.7551 | |||
Mean | 75.63 | 78.52 | |||||
Standard Deviation | 18.44 | 19.31 |
Outcome: I-QoL - Psychosocial impacts Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 46.34 | 50.04 | |||||
Standard Deviation | 26.08 | 27.44 | |||||
12 months |
N Analyzed | 53 | 62 | 0.4139 | |||
Mean | 77.88 | 78.01 | |||||
Standard Deviation | 17.12 | 20.66 |
Outcome: I-QoL - Social embarrassment Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 36.04 | 39.92 | |||||
Standard Deviation | 26.01 | 28.29 | |||||
12 months |
N Analyzed | 53 | 62 | 0.7216 | |||
Mean | 82.35 | 84.00 | |||||
Standard Deviation | 22.70 | 23.65 |
Outcome: BLUFTS - filling symptoms Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 4.87 | 5.08 | |||||
Standard Deviation | 2.63 | 2.72 | |||||
12 months |
N Analyzed | 53 | 62 | 0.4693 | |||
Mean | 2.80 | 2.97 | |||||
Standard Deviation | 1.95 | 2.37 |
Outcome: BLUFTS - voiding symptoms Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 1.75 | 1.81 | |||||
Standard Deviation | 2.66 | 2.28 | |||||
12 months |
N Analyzed | 53 | 62 | 0.1733 | |||
Mean | 1.84 | 1.36 | |||||
Standard Deviation | 2.64 | 1.94 |
Outcome: BLUFTS - incontinence symptoms Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 9.00 | 7.66 | |||||
Standard Deviation | 3.72 | 3.87 | |||||
12 months |
N Analyzed | 53 | 62 | 0.0210 | |||
Mean | 1.60 | 2.47 | |||||
Standard Deviation | 2.42 | 3.28 |
Outcome: BLUFTS - sexual function Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 1.30 | 1.08 | |||||
Standard Deviation | 1.54 | 1.41 | |||||
12 months |
N Analyzed | 53 | 62 | 0.3822 | |||
Mean | 0.20 | 0.42 | |||||
Standard Deviation | 0.45 | 1.12 |
Outcome: BLUFTS - QoL Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 7.87 | 6.89 | |||||
Standard Deviation | 4.55 | 4.22 | |||||
12 months |
N Analyzed | 53 | 62 | 0.2857 | |||
Mean | 1.98 | 2.15 | |||||
Standard Deviation | 3.31 | 3.32 |
Outcome: Max Flow (Qmax) Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 22.65 | 25.05 | |||||
Standard Deviation | 7.49 | 11.20 | |||||
12 months |
N Analyzed | 53 | 62 | 0.2048 | |||
Mean | 17.74 | 22.14 | |||||
Standard Deviation | 9.12 | 10.42 |
Outcome: PVR Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 15.19 | 19.80 | |||||
Standard Deviation | 19.89 | 29.99 | |||||
12 months |
N Analyzed | 53 | 62 | 0.3035 | |||
Mean | 24.00 | 40.29 | |||||
Standard Deviation | 23.35 | 46.04 |
Outcome: Diary - Nocturia Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 0.72 | 0.80 | |||||
Standard Deviation | 0.82 | 0.81 | |||||
12 months |
N Analyzed | 53 | 62 | 0.1740 | |||
Mean | 0.98 | 0.78 | |||||
Standard Deviation | 0.97 | 0.73 |
Outcome: Diary - Urgency episodes Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 2.54 | 2.79 | |||||
Standard Deviation | 3.25 | 3.74 | |||||
12 months |
N Analyzed | 53 | 62 | 0.3234 | |||
Mean | 2.42 | 1.55 | |||||
Standard Deviation | 3.24 | 2.23 |
Outcome: Diary - Urgency scale Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 2.07 | 211 | |||||
Standard Deviation | 1.00 | 0.98 | |||||
12 months |
N Analyzed | 53 | 62 | 0.8817 | |||
Mean | 1.85 | 1.89 | |||||
Standard Deviation | 1.18 | 0.96 |
Outcome: Incontinence VAS (I-VAS) Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | ND | |||
Mean | 6.61 | 6.69 | |||||
Standard Deviation | 2.15 | 2.14 | |||||
12 months |
N Analyzed | 53 | 62 | 0.4354 | |||
Mean | 0.95 | 1.20 | |||||
Standard Deviation | 2.41 | 2.31 |
Outcome: Time til return to house work Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.624 | |||
Mean | 7.18 | 5.43 | |||||
Standard Deviation | 12.15 | 9.89 |
Outcome: Time til return to job Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.207 | |||
Mean | 9.33 | 6.64 | |||||
Standard Deviation | 9.69 | 8.27 |
Outcome: Time til return to social activity Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.347 | |||
Mean | 14.33 | 11.41 | |||||
Standard Deviation | 20.31 | 17.17 |
Outcome: Time til return to hobby Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.442 | |||
Mean | 14.84 | 11.08 | |||||
Standard Deviation | 15.11 | 12.67 |
Outcome: Time til return to sexual activity Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | TVT-Secur U | TVT-Secur H | Minisling retropubic | Minisling obturator | Comparison Measure | TVT-Secur U vs. TVT-Secur H |
0 months |
N Analyzed | 53 | 62 | 0.885 | |||
Mean | 38.96 | 39.56 | |||||
Standard Deviation | 15.31 | 14.20 |
Adverse Events
Arm or Total | Title | Description | Follow-up time | In-hospital or After discharge | Is event serious? | Reported definition of serious event | Number affected | Number at risk (analyzed) | Difference between 2 slings (eg, OR/RR or %, with 95% CI) | Reported P value between slings | Comments |
---|---|---|---|---|---|---|---|---|---|---|---|
Minisling retropubic | dyspareunia | or lost libido | Unclear | After discharge | ND | ND | 0 | 53 | ND | ND | |
Minisling obturator | 0 | 62 | |||||||||
Total | |||||||||||
Minisling retropubic | Organ injury in OR (urethra, bladder, bowel) | Vaginal wall perforation | Intraop | In-hospital | ND | ND | 0 | 53 | ND | ND | |
Minisling obturator | 3 | 62 | |||||||||
Total | |||||||||||
Minisling retropubic | Immed postop retention | Periop | In-hospital | ND | ND | 2 | 53 | ND | ND | ||
Minisling obturator | 1 | 62 | |||||||||
Total | |||||||||||
Minisling retropubic | Return to OR | Persistent urine leakage necessitating additional sling surgery - not defined by arm | <12mo | After discharge | ND | ND | ND | 53 | ND | ND | |
Minisling obturator | ND | 62 | |||||||||
Total | 4 | 115 | |||||||||
Minisling retropubic | Obstruction requiring reoperation | <12mo | After discharge | ND | ND | ND | 53 | ND | ND | ||
Minisling obturator | ND | 62 | |||||||||
Total | 1 | 115 |